GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Somanetics Corporation (SMTS) [hlAlert]

Rating:
Buy SMTS
up 5.59 %

Somanetics Corporation (SMTS) rated Buy with price target $20 by Maxim Group

Posted on: Thursday,  Jun 18, 2009  10:25 AM ET by Maxim Group

Maxim Group rated Buy Somanetics Corporation (NASDAQ: SMTS) on 06/18/2009. Previously Maxim Group rated Buy Somanetics Corporation (NASDAQ: SMTS) on 01/16/2009.,
when the stock price was $16.62. Since then, Somanetics Corporation has gained 5.60% as of 07/28/2010's recent price of $17.55.
If you would have followed the previous Maxim Group's recommendation on SMTS, you would have gained 5.59% of your investment in 558 days.

Somanetics Corporation develops, manufactures and markets the In Vivo Optical Spectroscopy (INVOS) System, a non-invasive patient monitoring system that continuously measures changes in the blood oxygen levels in the brain and elsewhere in the body in tissues beneath the sensor in patients with or at risk for restricted blood flow. The INVOS System consists of a portable monitoring system, including technology, which is used with multiple single-use disposable sensors, called SomaSensors or OxyAlert sensors. During the fiscal year ended November 30, 2008 (fiscal 2008), net revenues from disposable sensors comprised approximately 72% of its net revenues. As of November 30, 2008, the Company had an installed base of 2,523 INVOS System monitors in the United States in 714 hospitals, and during fiscal 2008, it sold 424,647 sensors worldwide. In November 2008, it acquired ICU Data Systems, Inc., a technology development company,

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/18/2009 10:25 AM Buy
None
17.06 20.00
as of 12/31/2009
1 Week up  44.81 %
1 Month up  74.31 %
3 Months up  54.96 %
1 YTD up  46.42 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/22/2009 10:25 AM Buy
None
14.28 18.00
1/16/2009 10:25 AM Buy
None
16.62 22.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy